newsfilter
← Latest News
PR Newswire·

INVOcell Review Published in Current Opinion in Obstetrics and Gynecology

SARASOTA, Fla., Oct. 21, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ:INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell ® medical device